1. Methods of treatment of weight loss in patients with depression dominant, which includes the identification of patients suffering from major depressive disorder wherein the patient also suffers overweight or obese, and a decrease in patients weight by assigning naltrexone or a pharmaceutically acceptable salt thereof and bupropion or a pharmaceutically acceptable salt thereof, wherein the naltrexone or pharmaceutically acceptable salt thereof present in an amount sufficient to effectively enhance the activity of bupropion or e a pharmaceutically acceptable soli.2. A method according to claim 1, further comprising the drugs used to alleviate symptoms of depression patsienta.3. A method according to claim 1, wherein the diagnosis "major depressive disorder" delivered to the patient via the Montgomery-Asberg depressii.4 scales for evaluation. A method according to claim 1, wherein the diagnosis "major depressive disorder" delivered to the patient using the "Questionnaire depressive symptoms" .5. A method according to claim 1, wherein the patient has no bipolar rasstroystvo.6. A method according to claim 1, wherein the patient has excess ves.7. The method of claim 1, wherein the patient suffers ozhireniem.8. The method of claim 1, wherein the patient is zhenschinoy.9. A method according to claim 1, wherein a combination of drugs that cause weight loss, administered at least once a den.10. A method according to claim 1, wherein a combination of drugs that cause weight loss, administered more than once a den.11. A method according to claim 1, wherein a combination of drugs that cause weight loss, administered for at least 12 nedel.12. A method according to claim 1, wherein a combination of drugs that cause a1. Способы проведения терапии потери веса у пациентов с доминирующей депрессией, который включает выявление пациентов, страдающих тяжелым депрессивным расстройством, при котором пациент страдает также избыточным весом или ожирением, и снижение веса пациента путем на
